Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Evotec SE

Evotec specializes in research and development services for the pharmaceutical and biotechnological industries. The group's activity is organized around 3 areas:

- development of broadband screening systems;

- research and development of pharmaceutical products: for the neurologic, oncologic, inflammatory diseases treatment;

- other: target identification, pharmacological tests development, broadband screening services, etc.

Net sales are distributed geographically as follows: Germany (11.9%), the United States (37.8%), France (23.4%), the United Kingdom (10.4%) and other (16.5%).

Number of employees : 2 178 people.
Sales per Businesses
20162017Delta
EUR (in Million)%EUR (in Million)%
EVT Execute137.8583.8%213.7883% +55.08%
EVT Innovate26.6616.2%43.8517% +64.51%
Sales per Regions
20162017Delta
EUR (in Million)%EUR (in Million)%
Europe97.0659%---
United States65.8040%97.4937.8% +48.15%
Japan and Rest of the World1.651%---
Germany--30.7511.9%-
United Kingdom--26.8210.4%-
France--60.1823.4%-
Rest of the World--42.3916.5%-
Managers
NameAgeSinceTitle
Werner Lanthaler, PhD512009Chief Executive Officer
Wolfgang Plischke682014Chairman-Supervisory Board
Craig L. Johnstone-2019Chief Operating Officer & Member-Management Board
Enno Spillner, MBA492016Chief Financial Officer
Cord E. Dohrmann, PhD552010Chief Scientific Officer
Claus Tycho Bræstrup, MD742013Independent Member-Supervisory Board
Bernd Hirsch492013Vice Chairman-Supervisory Board
Iris Löw-Friedrich MD, PhD592014Independent Member-Supervisory Board
Elaine Sullivan, PhD592015Member-Supervisory Board
Michael Shalmi MD, MBA542017Member-Supervisory Board
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 150,123,640 135,178,129 90.0% 249,915 0.2% 90.0%
Shareholders
NameEquities%
Novo Nordisk Fonden 14,767,926 9.91%
Roland Oetker 13,510,453 9.06%
Allianz Global Investors GmbH 7,222,659 4.85%
DWS Investment GmbH 6,278,449 4.21%
Norges Bank Investment Management 3,700,512 2.48%
The Vanguard Group, Inc. 3,491,451 2.34%
Deka Investment GmbH 2,366,512 1.59%
Goldman Sachs Asset Management LP 2,207,522 1.48%
BlackRock Asset Management Deutschland AG 2,205,535 1.48%
Principal Global Investors LLC 1,843,682 1.24%
Holdings
NameEquities%Valuation
Evotec SE (EVT) 249,9150.17%4,961,013 USD
Markets and indexes
- Börse Frankfurt
- Prime Standard
- MDAX /
Stock Exchange Codes
- Bloomberg Code :  EVT.NM
- Reuters Code :  EVTG.F
- Datastream Code :  D:EVT
Company contact information
Evotec SE
Manfred Eigen Campus Essener Bogen 7
DE-22419 Hamburg, Hamburg
Germany

Phone : +49 (0) 40 5 60 81 0
Fax : +49 (0) 40 5 60 81 222
Internet : http://www.evotec.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
EVOTEC SE19.32%3 417
IQVIA HOLDINGS INC33.94%30 481
LONZA GROUP35.77%25 846
CELLTRION, INC.--.--%18 845
INCYTE CORPORATION22.85%17 466
EXACT SCIENCES CORPORATION64.77%13 463
SEATTLE GENETICS, INC.30.62%12 577
GALAPAGOS82.29%10 010
ALNYLAM PHARMACEUTICALS, INC.18.64%9 619
IONIS PHARMACEUTICALS INC16.00%8 811
SAGE THERAPEUTICS INC72.60%8 540
ICON PLC19.74%8 367
QIAGEN-2.26%7 625
BIO-TECHNE CORP38.50%7 595
CHARLES RIVER LABORATORIES INTL. INC22.50%6 767
PRA HEALTH SCIENCES INC15.97%6 697
HANGZHOU TIGERMED CONSULTING CO LTD--.--%6 532
ACADIA PHARMACEUTICALS INC.151.95%6 141
SYNEOS HEALTH INC39.57%5 683
ALLOGENE THERAPEUTICS INC22.50%4 016
BLUEPRINT MEDICINES CORP50.06%3 973
Connections : Evotec SE
ERT, Inc. /PA/
SYNLAB Ltd.
Momentum Gruppen A/S
German Chemical Industry Fund
Bayer Real Estate GmbH
University of Hohenheim
Paul Ehrlich-Foundation
Bayer Innovation GmbH
Technology Academy Finland
European Chemical Industry Council
Bundesverband der Deutschen Industrie e.V.
German Asia Pacific Business Association
Robert Koch Stiftung eV
Walter Siegenthaler Gesellschaft
Xellia Holdco A/S
IOLTECH SA
Cimex Medical Innovations LC
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Bankinvest Biomedical Venture
Refugees International, Inc.
The Royal Danish Scientific Society
Evotec (UK) Ltd.
Vital Voices Global Partnership, Inc.
Bertelsmann, Inc.
Penguin Random House LLC
Carrick Therapeutics Ltd.
Penguin Random House Ltd.
IP Group Plc /Venture Capital/
Hoechst Marion Roussel, Inc.
Bayer Technology Services GmbH
Johann Wolfgang Goethe-Universität Frankfurt am Main
Concentro Management AG
Biom Venture Capital GmbH & Co. Fonds KG
FSHD Unlimited Cooperatie Ua
Novo Principal Investments
Eternygen GmbH
Aerocrine AB
SYNLAB International GmbH
ERT Holdco A/S
Ataxion, Inc.
Novo Invest 1 A/S
Topas Therapeutics GmbH